top of page
32200c5c-7c4c-438f-a9df-3119a2398bf2.png
Autchmaber1.png
ai-cvd.png
AI-CVD Summary
Coronary Calcification
816_aicvd (8)_4_edited.jpg
‌ Aortic Calcification
ٍEpicardial Fat _edited.jpg
Epicardial Fat
816_aicvd (8)_5_edited.jpg
Cardiac Chambers
816_aicvd (8)_7_edited.jpg
Aorta & PA Size
816_aicvd (8)_10_edited.jpg
Lung LAI
816_aicvd (8)_9_edited.jpg
Lung HAI
816_aicvd (8)_11_edited.jpg
Liver Fat
816_aicvd (8)_12_edited.jpg
Muscle & Visceral Fat
816_aicvd (8)_13_edited.jpg
Bone Density
f055739f-1956-41a1-8156-cda95d1fea9f.png
AI-CVD Bundle
Muscle and Fat Analysis.png
Liver Attenuation.png
Cardiac Chambers Volumetry.png
ٍEpicardial Fat .png
Bone Mineral Density (BMD) .png
coronaryArteryCalcification.png
Lung Density Report- High Attenuation Index.png
Thoracic Aorta and Pulmonary Artery Sizing .png
Aortic Wall Aortic and Mitral Valve Report.png
Lung Density Report- Low Attenuation Index.png
AI-CVD--.png
Frame 1000008286.png
Frame 1000008286.png
Frame 1000008287.png

AI-enabled Cardiac Chambers Volumetry in Non-Contrast Cardiac CT scans Detect HFrEF vs. HFpEF

Nov 27, 2024
2 min read

Updated: Oct 2



AUTHORS (FIRST NAME, LAST NAME):

Kyle Atlas, Chenyu Zhang, Anthony P. Reeves, Emily Jaalouk, Sanjay Manubolu, Song Shou Mao, Matthew Budoff, Morteza Naghavi.


1. The Lundquist Institute, Torrance, CA

2. HeartLung.AI, Houston, TX

3. Cornell University, Ithaca, NY


Abstract:


Introduction:

We examined whether artificial intelligence (AI)-enabled volumetry of cardiac chambers (AutoChamber) utilizing the CAC scan may distinguish heart failure with reduced ejection fraction (HFrEF) versus heart failure with preserved ejection fraction (HFpEF).


Methods:

We applied AI-enabled automated cardiac chambers to data from 75 patients who underwent both a cardiac CT scan and echocardiography at Harbor UCLA medical center. AutoChamber took on average 21 seconds per scan and reported estimated volume for left atrium (LA), left ventricle (LV), right atrium (RA), and right ventricle (RV). LV volume was indexed (LVVI) by dividing LV volume by body surface area (BSA) to allow a more accurate assessment of the size of the left ventricle relative to the size of the individual. The average BSA for males and female were 1.59 ± 0.3 and 1.29 ± 0.2, respectively. HFrEF and HFpEF were defined as EF<40% and EF>50% respectively.


Results:

Average EF was 57.5 ± 7.0 in males and 59.7 ± 8.1 in females, respectively. AutoChamber volume for HFpEF vs HFrEF were LA (84.8±35.3 vs 113.2±32.8 p=0.002), LV (109.9±36.7 vs 170.7±65.9 p=0.0007), RA (97.5±58.3 vs 117.2±51.1 p=0.18), RV (135.6±52.1 vs 176.2±70.8 p=0.008), LVW mass (116.1±39.1 vs 170.6+56.9 p=0.0005). Density plots in the figure show a clear distinction between HFpEF and HFrEF using AI measured LVVI and comparable results


Conclusion:

AI-enabled automated cardiac chambers volumetry can correlate well with echocardiography based LVVI and detects HFrEF vs HFpEF. Further studies are needed to evaluate the ability of AutoChamber for prospective detection of patients at risk of HFrEF vs HFpEF.




Abstract Graphic/Image Description:

AI-CAC LV volume index (LVVI) defined as LV volume divided by BSA was able to distinguish HFrEF vs. HFpEF (58.4±16.2 vs. 85.6±27, p=0.0005) comparably to echocardiography LVVI (50.7±14.9 vs. 85.7±27.3, p<0.0001). Density plots in the figure show a clear distinction between HFpEF and HFrEF using AI measured LVVI and comparable results.



Comments


Ready to Unlock the Value in Your CT Scans?

Join leading healthcare providers using AI-CVD to save lives and increase revenue, and lead the future of preventive cardiology.

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Youtube

2450 Holcombe Blvd
TMC Innovations
Houston, TX 77021

aicvd patent_edited_edited.jpg
ISO LOGO_edited.png
autoliver patent.png

©2026 HeartLung Corporation. All Rights Reserved. US Patent Nos US9119590*, US10695022, US11610686, US18167691, US20240115224, and Patents Pending. AI-CVD, AI-CAC, AutoBMD, AutoCAC, AutoChamber and other trademarks shown on this website are protected under intellectual property rights of HeartLung Corporation in the United States.

bottom of page